公司概覽
業務類別 Biotechnology
業務概覽 Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.
公司地址 899 Halei Road, Building B, Pudong, Shanghai, CHN, 201203
電話號碼 +86 2161632588
傳真號碼 +86 2161632570
公司網頁 https://www.zailaboratory.com
員工數量 1784
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Joshua Smiley Chief Operating Officer and President 美元 667.06K 29/04/2025
Dr. Samantha Du, PhD Chairperson of the Board and Chief Executive Officer 美元 901.05K 26/02/2026
Dr. Rafael G. Amado, M.D. President and Head of Global Research and Development 美元 636.28K 29/04/2025
Mr. Frazor Titus Edmondson, III Chief Legal Officer 美元 585.88K 29/04/2025
Dr. Yajing Chen, PhD Chief Financial Officer and Principal Accounting Officer 美元 502.50K 26/02/2026
 
董事會成員
董事會 職務 更新日期
Dr. John D. Diekman,PhD Lead Independent Director 26/02/2026
Mr. Leon Oliver Moulder, Jr Independent Director 26/02/2026
Mr. Peter Karl Wirth, J.D. Independent Director 26/02/2026
Mr. William David Lis Independent Director 26/02/2026
Mr. Scott William Morrison Independent Director 26/02/2026
Dr. Samantha Du, PhD Chairperson of the Board and Chief Executive Officer 26/02/2026
Ms. Nisa Bernice Wing-Yu Leung, J.P. Independent Director 26/02/2026
Dr. Richard Brian Gaynor, M.D. Independent Director 26/02/2026
Mr. Michel Pericles Vounatsos Independent Director 26/02/2026
 
所屬ETF (更新日期: 07/03/2026 04:52)
代號 名稱 佔比% 持有日期
IBBiShares Biotechnology ETF0.57%28/02/2026
SBIOALPS Medical Breakthroughs ETF0.09%27/02/2026
BBPVirtus LifeSci Biotech Products ETF0.04%27/02/2026
DFEMDimensional Emerging Markets Cr Eq 2 ETF0.03%27/02/2026
DFAEDimensional Emerging Core Equity Mkt ETF0.03%27/02/2026
PGJInvesco Golden Dragon China ETF0.02%27/02/2026
FMEDFidelity Disruptive Medicine ETF0.02%27/02/2026
FNIFirst Trust Chindia ETF0.01%29/12/2022
APIEActivePassive International Equity ETF0.01%27/02/2026
NSINational Security Emerging Mkts Idx ETF0.004%27/02/2026
DFAXDimensional World ex US Core Eq 2 ETF0.003%27/02/2026
SPGMState Street® SPDR® Ptf MSCIGlbStkMktETF0.002%27/02/2026
IBBQInvesco Nasdaq Biotechnology ETF0.002%27/02/2026
BIBProShares Ultra Nasdaq Biotechnology0.002%27/02/2026
DFSEDimensional Emerging Mrkts Sstby Cr 1ETF0.002%27/02/2026
NTSEWisdomTree Emerging Mkts Effcnt Cr ETF0.0004%27/02/2026
EMCRXtrackers EM CarbReduc&ClimtImprvs ETF0.0002%24/02/2026
REMGSPDR Bloomberg SASB EM ESG Slct ETF0.0001%31/03/2023
AOMiShares Core 40/60 Moderate Allc ETF<0.000001%27/02/2026
CGNGCapital Group New Geography Equity ETF<0.000001%31/12/2025
 1    2  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.